And

are now a part of the new and improved

search Created with Sketch.
search Created with Sketch.

Advertisement

Topic: Psoriasis

DermWireTV: Climate Change and Skin, Wynzora, Tremfya, Rinvoq Updates thumbnail
Play Button

DermWireTV: Climate Change and Skin, Wynzora, Tremfya, Rinvoq Updates

Series: DermWire TV | July 30, 2020

The vast majority of dermatologists around the world—95.6 percent—believe climate change is occurring, and 88 percent think it will impact the incidence of skin diseases, according to the first international survey of dermatologists on the topic, conducted online by the International Society of Dermatology's Climate Change Committee. FDA has approved MC2 Therapeutics Wynzora Cream for once-daily topical treatment of plaque psoriasis in adults. Tremfya is the first IL-23 inhibitor FDA-approved for active psoriatic arthritis. AbbVie's upadacitinib met both primary and all secondary endpoints in Measure Up 2, the second Phase 3 study in individuals with moderate to severe atopic dermatitis.

Watch Video
What Skincare Products are Best for Psoriasis? thumbnail
Play Button

What Skincare Products are Best for Psoriasis?

Series: Ask Dr. Friedman | July 1, 2020

Not many topical formulations tout benefits for psoriasis, but that doesn't mean there are no useful products. Dr. Friedman offers his take.

Watch Video
DermWireTV: COVID-19 Loans, Taltz for Peds, Finacea Returns thumbnail
Play Button

DermWireTV: COVID-19 Loans, Taltz for Peds, Finacea Returns

Series: DermWire TV | April 16, 2020

SBA Loans and Paycheck Protection Program (PPP) loans for practices impacted by the coronavirus pandemic are among the options addressed in a new video series, “Coping with COVID-19.”  Eli Lilly and Company's Taltz is now approved to manage moderate to severe plaque psoriasis in pediatric patients ages 6 to under 18. LEO Pharma’s Finacea Foam (azelaic acid 15%) is back in pharmacies—just in time for Rosacea Awareness Month.

Watch Video
Psoriasis Update: Understanding the Latest Psoriasis Guidelines thumbnail
Play Button

Psoriasis Update: Understanding the Latest Psoriasis Guidelines

Series: Dermatology Dispatches | April 10, 2020

In a major reversal, the latest psoriasis guidelines recommend against yearly tuberculosis testing for psoriasis patients on biologics who are at low or no risk for TB, says Jashin J. Wu, MD. He also sheds light on studies comparing the 11 biologics that are currently approved for the treatment of psoriasis.

Watch Video
IL-23 Inhibitors: Update on Safety and Dosing thumbnail
Play Button

IL-23 Inhibitors: Update on Safety and Dosing

Series: Dermatology Dispatches | April 9, 2020

With more experience using IL-23 inhibitors to treat psoriasis, dermatologists are seeing high levels of patient satisfaction and no new safety signals. Jennifer Cather, MD assesses the clinical experience.

Watch Video

Advertisement

The Latest in Psoriasis

Advertisement

View more